Breaking Research News from Breastcancer.org
Comments
-
Perjeta Improves Overall Survival in HER2-Positive, Metastatic Disease
June 22, 2012
More results from the CLEOPATRA study show that women who got Perjeta, Herceptin, and Taxotere had better overall survival than women who got only Herceptin and Taxotere. Read more...0 -
Experimental Vaccine May Help Reduce Recurrence Risk of HER2-Positive Disease
June 25, 2012
A new study has found that an experimental vaccine targeting HER2-positive breast cancer cells lowered the risk of the cancer coming back in women diagnosed with HER2-positive, early-stage breast cancer. Read more...0 -
FDA Advisory Panel Approves MarginProbe System
June 26, 2012
An FDA expert panel voted to approve the MarginProbe system - a device that helps surgeons decide if all the cancer tissue has been removed during lumpectomy. Read more...0 -
Mammogram Rates Have Dropped After Task Force Recommendation
July 3, 2012
A study found that fewer women in their 40s are getting screening mammograms since the U.S. Preventive Services Task Force recommended that screening mammograms start at age 50 instead of 40. Read more...0 -
Daily Exercise - At Any Intensity Level - May Lower Risk
July 6, 2012
A study has found that women who got about 2 hours of exercise each day -- at any intensity level -- were about 30% less likely to develop breast cancer than women who didn't exercise that much. Read more...0 -
Large Review Study Says Avastin Offers Only Modest Benefits for Metastatic Breast Cancer
July 11, 2012
Results from a new large review study show that Avastin offers only modest benefits for stopping the growth and spread of metastatic breast cancer. Read more...0 -
About 20% of Women Need More Surgery After Lumpectomy
July 18, 2012
A British study has found that about 20% of women who have lumpectomy have to have more surgery once their doctors have all the information about the cancer and breast tissue that was removed. Read more...0 -
Aromatase Inhibitors Seem Less Effective in Obese Women
July 20, 2012
A small study found that while obese women diagnosed with early-stage, hormone-receptor-positive breast cancer who took Arimidex and Femara had lower estrogen levels than before they started treatment, their estrogen levels were still more than double those of women at a healthy weight. Read more...0 -
Afinitor Approved to Treat Advanced-Stage, Hormone-Receptor-Positive Disease
July 24, 2012
Afinitor has been approved to be used in combination with Aromasin to treat advanced-stage, hormone-receptor-positive, HER2-negative breast cancer in postmenopausal women that has already been treated with Femara or Arimidex. Read more...0 -
Accelerated Radiation May Be as Good as Standard Schedule to Lower DCIS Recurrence Risk
July 31, 2012
Research suggests that a shorter, higher-dose radiation schedule after lumpectomy to remove DCIS may reduce recurrence risk just as much as a standard radiation treatment schedule. Read more...0 -
Fertility Drugs Seem to Affect Breast Cancer Risk in Younger Women
August 3, 2012
A study suggests that women younger than 50 who use fertility drugs to successfully conceive a child may see their risk of breast cancer go up. But this higher risk is about the same as the average woman's risk. Read more...0 -
Injectable Herceptin Shows Promise
August 10, 2012
A study suggests that an injectable form of Herceptin works just as well as and is as safe as the standard IV form of Herceptin to treat HER2-positive, early-stage breast cancer before surgery. Read more...0 -
Most Older Women Seem to Benefit from Radiation After Lumpectomy
August 15, 2012
Contrary to current treatment guidelines, a new study suggests that radiation therapy after lumpectomy may help most older women diagnosed with early-stage, hormone-receptor-positive breast cancer avoid a later mastectomy. Read more...0 -
Research Suggests How Metastatic Cancer Becomes Resistant to Chemotherapy
August 15, 2012
A very early study on cancer cells in petri dishes in the lab has found that a type of cell called a fibroblast also is damaged by chemotherapy. Damaged fibroblasts make a protein called WNT16B that may help metastatic cancer cells become resistant to chemotherapy and grow. Read more...0 -
Docs Need to Consider Quality of Life When Assessing Lymphedema
August 16, 2012
A study strongly suggests that considering a person's quality of life as well as reducing swelling is very important to managing lymphedema. Read more...0 -
Xgeva Better Than Zometa at Reducing Risk of Bone Problems in Women with Metastatic Disease
August 21, 2012
Research suggests that Xgeva is better than Zometa at reducing the risk of bone complication and improves quality of life more in women diagnosed with metastatic breast cancer that has spread to the bones. Read more...0 -
Chemo During Pregnancy Appears Safe for Mother and Child
August 21, 2012
A study supports other research that suggests chemotherapy during pregnancy doesn't have harmful effects on the baby. Read more...0 -
Exercise Improves Quality of Life During and After Treatment
August 22, 2012
Two new, separate review studies found that 12 weeks of exercise was linked to better overall quality of life for people being treated for cancer as well as survivors. Read more...0 -
Survey Says Women Want to See Reconstruction Results Before Breast Cancer Surgery
August 23, 2012
Survey results reveal that 89% of U.S. women diagnosed with breast cancer want to see what reconstruction results would look like before starting treatment. Read more...0 -
New Tool May Help Figure Out Which Older Women Can Skip Radiation After Lumpectomy
August 28, 2012
To help doctors better understand which older women can safely skip radiation therapy after lumpectomy, researchers have developed a new predictive tool. Read more...0 -
T-DM1 Improves Survival in Women with HER2-Positive Metastatic Breast Cancer
August 29. 2012
Women diagnosed with HER2-positive metastatic breast cancer lived longer when they got the experimental medicine T-DM1 compared to women who got a different targeted therapy regimen. Read more...0 -
Obese and Overweight Women May Have Higher Risk of Recurrence
August 30, 2012
A large study suggests that overweight and obese women diagnosed with early-stage, hormone-receptor-positive breast cancer have a higher risk of the cancer coming back and are less likely to survive the disease. Read more...0 -
Lack of Sleep Linked to Higher Risk of Recurrence of Estrogen-Receptor-Positive Disease in Postmenopausal Women
August 30, 2012
A small study suggests that not getting enough sleep may be linked to a higher recurrence risk for early-stage, estrogen-receptor-positive breast cancer in postmenopausal women. Read more...0 -
Genes Associated with Breast Size Also Linked to Breast Cancer
August 30, 2012
A study found seven pieces of chromosomes that are associated with breast size; three of these also are associated with breast cancer. Read more...0 -
Having Dense Breasts Doesn't Influence Breast Cancer Survival
September 4, 2012
Research suggests that women with dense breasts have the same breast cancer survival rates as women whose breasts aren't dense. Read more...0 -
Some Women Having Mastectomy Opt for Nipple Banking, but Have More Complications
September 4, 2012
A small Dutch study has found that some women having mastectomy may want to bank their nipple so it can be attached later to their reconstructed breast. Read more...0 -
New BRCA1 and BRCA2 Test May Be More Accurate, Less Expensive
September 5, 2012
A group of Canadian scientists has developed a new way to test for abnormal BRCA1 and BRCA2 genes that seems to be more accurate and less expensive than the current testing methods. Read more...0 -
Study Suggests Organic Foods May Not Be More Nutritious, but Also Points Out How Much We Don't Know
September 5, 2012
An analysis of 237 studies didn't show that organic foods are substantially healthier than conventionally produced foods, but there were some limitations in the studies that were analyzed. Read more...0 -
Lying Face Down for Radiation Therapy to Treat Breast Cancer May Protect Healthy Tissue
September 11, 2012
A study suggests that lying face down to receive radiation therapy to the breast area reduces the amount of radiation that unintentionally reaches the heart and lungs. Read more...0 -
Combination of Arimidex and Faslodex Better Than Arimidex Alone to Treat Metastatic Breast Cancer
September 12, 2012
A study has found that postmenopausal women diagnosed with hormone-receptor-positive metastatic breast cancer and treated with a combination of Arimidex and Faslodex as the first treatment for metastatic disease lived about 6 months longer than women treated only with Arimidex. Read more...0
